Skip to main content
. 2022 Feb 2;10(2):e003082. doi: 10.1136/jitc-2021-003082

Table 1.

Clinicopathological features of patients used in the study

Patient Expansion success Age Sex Smoking history Histology Treatment prior to surgery pStage (AJCC 7) Survival
1 Y 61 M Former smoker SCC None 1 Alive
2 N 73 F Former smoker SCC Chemotherapy 0 Alive
3 N 75 F Former smoker Adenocarcinoma Chemotherapy 3 Alive
4 Y 74 F Former smoker Adenocarcinoma None 1 Alive
5 N 74 M Former smoker SCC None 2 Dead
6 Y 70 F Former smoker SCC None 3 Dead
7 Y 83 M Former smoker SCC None 3 Alive
8 N 74 M Former smoker Adenocarcinoma None 1 Alive
9 Y 66 M Former smoker SCC None 2 Alive
10 Y 76 M Former smoker Adenocarcinoma None 2 Alive
11 N 74 F Former smoker Adenocarcinoma Chemotherapy 1 Alive
12 N 69 M Former smoker Adenocarcinoma Chemotherapy 0 Alive
13 Y 72 F Former smoker Adenocarcinoma None 3 Alive
14 Y 74 M Former smoker Adenocarcinoma None 2 Alive
15 Y 58 M Former smoker Adenocarcinoma Chemotherapy 3 Alive
16 Y 60 M Former smoker Large cell Chemotherapy 3 Alive

AJCC, American Joint Committee on Cancer; F, female; M, male; SCC, squamous cell carcinoma.